Related references
Note: Only part of the references are listed.Rational Design of Antibody Protease Inhibitors
Tao Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
An Immunosuppressive Antibody-Drug Conjugate
Rongsheng E. Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists
Tao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody
Yong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
An Antibody with a Variable-Region Coiled-Coil Knob Domain
Yong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Rational Design of CXCR4 Specific Antibodies with Elongated CDRs
Tao Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
An Antibody CDR3-Erythropoietin Fusion Protein
Yong Zhang et al.
ACS CHEMICAL BIOLOGY (2013)
Functional Antibody CDR3 Fusion Proteins with Enhanced Pharmacological Properties
Yong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells
Inna V. Grishkan et al.
CELLULAR IMMUNOLOGY (2013)
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+T Effector Memory Lymphocytes
Lina Hu et al.
PLOS ONE (2013)
Structure, Function, and Chemical Synthesis of Vaejovis mexicanus Peptide 24: A Novel Potent Blocker of Kv1.3 Potassium Channels of Human T Lymphocytes
Georgina B. Gurrola et al.
BIOCHEMISTRY (2012)
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
Eric J. Tarcha et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells
Zoltan Varga et al.
MOLECULAR PHARMACOLOGY (2012)
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
Agnes E. Coutinho et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus
Stella A. Nicolaou et al.
CELL CALCIUM (2010)
Efficacy and Cytokine Modulating Effects of Tacrolimus in Systemic Lupus Erythematosus: A Review
Kam Hon Yoon
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library
Zoltan Takacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Memory T cells need CD28 costimulation to remember
Alina C. Boesteanu et al.
SEMINARS IN IMMUNOLOGY (2009)
Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus
C. Poulopoulou et al.
ARTHRITIS AND RHEUMATISM (2008)
Altered dynamics of kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus
Stella A. Nicolaou et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis
Philippe Azam et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Christine Beeton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases
A Schmitz et al.
MOLECULAR PHARMACOLOGY (2005)
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases
C Beeton et al.
MOLECULAR PHARMACOLOGY (2005)
K+ channels as targets for specific immunomodulation
KG Chandy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
CD28nullCD4+ T cells -: Characterization of an effector memory T-cell population in patients with rheumatoid arthritis
AER Fasth et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile
RE Middleton et al.
BIOCHEMISTRY (2003)
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
H Wulff et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes
CN Ellis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
